Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04754035
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-10-03
First Post:
2017-07-07
Brief Title:
Clinical Study With Ibrutinib and Venetoclax for Patients With RelapsedRefractory Chronic Lymphocytic Leukemia
Sponsor:
Paolo Ghia
Organization:
IRCCS San Raffaele
Organization Data
Organization:
IRCCS San Raffaele
Class:
OTHER
Study ID:
PS-CLL-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Paolo Ghia
Lead Sponsor Class:
OTHER
Responsible Party:
Paolo Ghia
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
IRCCS San Raffaele
Old Name:
None
Old Organization:
None